STAAR Surgical Company
NASDAQ: STAA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Warren Foust
- Employees
- 1,157
- Headquarters
- Lake Forest, United States
- IPO year
- 1992
- Market cap
- $1.4B
- Website
- https://www.staar.com
Loading STAA…
Loading profile data…Frequently asked questions about STAA
What does STAAR Surgical Company (STAA) do?
STAAR Surgical Company, along with its subsidiaries, specializes in ophthalmological solutions, focusing on the design, development, manufacturing, and commercialization of implantable lenses for vision correction, complete with the sophisticated delivery systems necessary for their implantation. A core offering is the Visian implantable Collame...
Where does STAA trade?
STAAR Surgical Company (STAA) trades on the NASDAQ Global Market.
What sector is STAA in?
STAAR Surgical Company (STAA) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of STAAR Surgical Company?
Warren Foust is the chief executive officer of STAAR Surgical Company (STAA).
Where is STAAR Surgical Company headquartered?
STAAR Surgical Company is headquartered in United States.
Does STAA pay a dividend?
STAAR Surgical Company (STAA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did STAA go public?
STAAR Surgical Company (STAA) completed its initial public offering in 1992.